company background image
HINOON logo

Highnoon Laboratories KASE:HINOON Stock Report

Last Price

PK₨724.55

Market Cap

PK₨38.4b

7D

-0.07%

1Y

120.5%

Updated

22 Jun, 2024

Data

Company Financials

Highnoon Laboratories Limited

KASE:HINOON Stock Report

Market Cap: PK₨38.4b

HINOON Stock Overview

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

HINOON fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends4/6

Highnoon Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Highnoon Laboratories
Historical stock prices
Current Share PricePK₨724.55
52 Week HighPK₨745.00
52 Week LowPK₨329.00
Beta0.30
11 Month Change9.73%
3 Month Change40.83%
1 Year Change120.48%
33 Year Change69.25%
5 Year Change381.86%
Change since IPO20,255.08%

Recent News & Updates

Recent updates

Shareholder Returns

HINOONPK PharmaceuticalsPK Market
7D-0.07%-0.7%2.0%
1Y120.5%87.9%65.5%

Return vs Industry: HINOON exceeded the PK Pharmaceuticals industry which returned 91.3% over the past year.

Return vs Market: HINOON exceeded the PK Market which returned 64.4% over the past year.

Price Volatility

Is HINOON's price volatile compared to industry and market?
HINOON volatility
HINOON Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.3%
10% most volatile stocks in PK Market8.2%
10% least volatile stocks in PK Market3.2%

Stable Share Price: HINOON's share price has been volatile over the past 3 months.

Volatility Over Time: HINOON's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19842,295Adeel Haiderwww.highnoon-labs.com

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, respiratory, and urology; and generic products under various brands. The company serves Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, and internationally.

Highnoon Laboratories Limited Fundamentals Summary

How do Highnoon Laboratories's earnings and revenue compare to its market cap?
HINOON fundamental statistics
Market capPK₨38.39b
Earnings (TTM)PK₨2.64b
Revenue (TTM)PK₨20.95b

14.5x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HINOON income statement (TTM)
RevenuePK₨20.95b
Cost of RevenuePK₨10.76b
Gross ProfitPK₨10.19b
Other ExpensesPK₨7.55b
EarningsPK₨2.64b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)49.88
Gross Margin48.65%
Net Profit Margin12.61%
Debt/Equity Ratio7.8%

How did HINOON perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

60%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.